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Abstract  
Background: In dementia care a large number of treatment decisions are made by family 
carers on behalf of their family member who lacks decisional capacity, Advance Care 
Planning (ACP) can support such carers in the decision-making of care goals. However, 
given the relative importance of ACP in dementia care, the prevalence of ACP in 
dementia care is poor. 
Aim: To evaluate the effectiveness of ACP with family carers in dementia care homes.  
Design: Paired cluster randomized controlled trial. The intervention comprised: a 
trained facilitator; family education; family meetings; documentation of ACP decisions; 
and intervention orientation for GPs and nursing home staff.  
Setting/participants:  Twenty-four nursing homes with a dementia nursing category 
located in Northern Ireland, UK. Family carers of nursing home residents classified as 
having dementia and judged as not having decisional capacity to participate in ACP 
discussions.   
Results: The primary outcome was family carer uncertainty in decision-making about 
the care of the resident (DCS scale). There was evidence of a reduction in total DCS score 
in the intervention group compared with the usual care group (-10.5, 95% confidence 
interval -16.4 to -4.7; p < 0.001).  
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Conclusions: ACP was effective in reducing family carer uncertainty in decision-making 
concerning the care of their family member and improving perceptions of quality of care 
in nursing homes. Given the global significance of dementia, the implications for 
clinicians and policy makers include them recognising the importance of family carer 
education and improving communication between family carers and formal care 
providers.  
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What is already known on this topic? 
In dementia care a large number of treatment decisions are made by family carers on behalf of 
their family member who lacks decisional capacity, ACP can support such carers in the 
decision-making of goals of care.  
There is limited evidence that ACP has the potential to reduce inappropriate hospital 
admissions and health-care costs for individuals living with dementia. 
Studies have tested different interventions which target nursing home staff for education and 
a few have focused on the provision of information and education to family carers regarding 
the terminal nature of dementia. 
What this paper adds? 
There are five key elements to a successful ACP intervention: 1) a trained facilitator; 2) family 
education; 3) family meetings; 4) documentation of ACP decisions; and 5) orientation of GPs 
and nursing home staff to the intervention. 
An ACP intervention with the five key elements is effective in reducing family carer uncertainty 
in decision-making concerning the care of their family member and increasing family carer 
satisfaction in nursing home care. 
Family carer education is essential to enable family carers to weigh the burden or benefit of 
treatment options for advanced stages of dementia. 
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Introduction 
Advance care planning (ACP) has been defined as a process of discussion between a 
patient, their health care providers, and those close to them, about future care in the 
event that the patient may lose capacity to make decisions for themselves, as their 
illness progresses.1  As such, it has become viewed as a means of navigating the 
uncertainties at the end of life by identifying and supporting patients’ needs and 
preferences for care.  
 
While ACP is viewed as communication between a patient, their family and healthcare 
providers and designed to identify patient values and goals of care at the end of life, ACP 
has several documented outcomes. These outcomes include clarification of patient’s 
preferences, values and aims for future medical treatments and care; the identification 
of the refusal of specific future treatments should the patient later become unable to 
communicate; and the appointment of a person to take decisions on the patient’s behalf 
if they subsequently lose decisional capacity.1-3 
 
From both an ethical and clinical standpoint, understanding when a treatment becomes 
futile for a person with dementia is contested, especially as they enter the later stages 
of the disease and they lose decisional capacity. It is made more challenging if their 
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wishes have not been stated in advance. Family carers may then be required to make 
difficult and emotional choices about whether or not to proceed with a life sustaining 
treatment. 4-6 It is viewed that ACP is a mechanism to support family carers in the 
difficult decision-making of such goals of care.2-3, 7 Nonetheless, given the relative 
importance of ACP in dementia care, the prevalence of ACP in dementia care is poor. 8-
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Although guidelines for dementia care suggest that ACP should commence as early as 
possible10-12 most residents in nursing homes with advanced dementia do not have an 
advance care plan 13-14  This has generated calls for a systematic approach to ACP in 
nursing homes. 15-16 However, the ACP intervention studies to date have used different 
approaches, making comparisons and data synthesis difficult.  A systematic review of 
ACP in nursing homes17 reported that ACP definitions vary across studies.  The absence 
of detail on interventions makes it difficult to integrate evidence to determine best 
practice for ACP in nursing homes.  Hence, the purpose of this study was to articulate a 
family focused ACP intervention and evaluate its impact in dementia care nursing 
homes. To help family carers participate in decision-making on goals of care at the end 
of life they need to understand the course of dementia, possible complications and 
therapeutic options.18  Recognizing the uncertainty experienced by family carers in this 
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process the primary hypothesis was that the ACP intervention would reduce family carer 
uncertainty in decision-making concerning the care of the family member.  We also 
wanted to test whether the ACP intervention would yield higher family carer satisfaction 
with nursing home care; reduce family carer psychological distress; reduce nursing 
home resident hospitalisations; reduce hospital deaths; and, increase the number of 
completed Do Not Resuscitate (DNR) orders.   
 
Methods 
As ACP is introduced into practice at the unit level (rather than at individual level), a 
paired cluster randomized trial was used. Nursing homes for the study were drawn from 
the largest independent private provider of health and social care services, and at 
commencement (September 2014) this provider had 74 nursing homes in Northern 
Ireland (NI).  The expression ‘nursing homes’ describes facilities in the UK that provide 
care to residents who require continual nursing care. Homes eligible to participate in the 
study were those given a dementia nursing category by NI’s Regulation and Quality 
Improvement Authority (RQIA).  In total, 24 nursing homes were identified and matched 
into pairs by the number of dementia beds in the facility.  Randomisation occurred at 
the paired facility level where the 24 nursing homes were randomly assigned (12 nursing 
homes per treatment) to ACP with usual care (intervention group) versus usual care 
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alone (control group).  The random number generator in Excel was used when a pair of 
nursing homes was ready to be enrolled, such that one was allocated to intervention 
and one to usual care at the same time. This was done by a member of the research 
team with no knowledge of the nursing home, and the allocation was concealed until 
after both homes in the pair had confirmed their willingness to join the study. 
Recruitment of the 24 homes took place in a staggered manner over nine months. 
 
Participants and recruitment procedure 
In the participating nursing homes, resident records were reviewed by the nursing home 
manager to identify those individuals classified as having dementia and judged as not 
having decisional capacity to complete an ACP.  For each eligible resident, the nursing 
home manager also completed a Functional Assessment Staging Tool (FAST) score.19  
This tool was designed to assess the stage of dementia by outlining key symptoms.  
Following identification of eligible residents, the family members most responsible for 
care of each resident were identified as potential study participants. These individuals 
were mailed a pre-notification letter by the nursing home manager endorsing the study 
and extending an invitation to an information event held at the nursing home.  In 
parallel, the nursing home manager identified resident General Practitioners (GPs) and 
other health and social care providers who they felt should receive a letter to inform 
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them about the study. Following the information event, and randomization a 
recruitment baseline questionnaire package was mailed to the potential participant’s 
home address by the nursing home administrator.  Non-respondents were sent a 
reminder postcard and then, if necessary, a replacement questionnaire.  Respondents 
in the intervention group were invited to participate in up to two family meetings with 
the ACP facilitator.  A follow-up questionnaire was mailed to them six weeks after 
baseline.  Participants in the usual care group completed a follow-up questionnaire only.  
The research team mailed the follow-up questionnaire package to participants, and, as 
in baseline data collection, with two further points of contact if necessary.  As a gesture 
of appreciation for participating in the project participants who completed both survey 
rounds where entered into a raffle for a small prize.  
 
Ethics 
Ethical approval was obtained from the regional Office of Research Ethics Committees 
Northern Ireland (ORECNI) (Ref. 14/NI/0082) and the Queen’s University Belfast 
Research Governance Office.  Participants gave informed consent before taking part and 
signed a consent form. 
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ACP intervention 
The combination of components for this intervention represents elements identified as 
important to ACP: a trained ACP facilitator; family education; family meetings; 
documentation of advance care plan decisions; and orientation of GPs and nursing home 
staff to the intervention.1-3, 15, 20-22  Prior to the launch of the trial two nursing homes 
participated in a pilot of the study protocol resulting in no change to the intervention.  
 
The ACP facilitator selected for this role was a Registered Nurse with minimum of three 
years post registration experience and a minimum of two years working in a field related 
to palliative care.  In preparation for their role in this project the selected candidate 
completed the Respecting Choices ‘Online ACP Facilitator Curriculum’23 and ‘The End of 
Life Care for All’ (e-ELCA)24 online training programmes, augmented with face-to-face 
orientation on ACP and dementia by local expertise.  
 
Family meetings were typically scheduled in the nursing home by the ACP facilitator. 
Prior to the meeting, participants were mailed the booklet “Comfort care at the end of 
life for persons with Dementia – a guide for caregivers (Northern Ireland version)”.  
Originally developed in Canada, this booklet provided information on the trajectory of 
the disease, clinical issues, decision-making processes, and symptom management.25  It 
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has shown a high level of acceptability,18, 26-27 and has been identified as a best practice 
instrument.28  Prior to use in this study the original booklet was reviewed by an expert 
panel including a service user, before being pilot tested to assure that the contents 
resonated with culture and practice in NI.  
 
The structure (preparing, conducting and documentation) of the family meeting was 
based on clinical practice guidelines developed for conducting family meetings.29  In the 
initial family meeting the contents of the booklet were reviewed and the family carers 
were assisted by the ACP facilitator to reflect on the resident’s goals, values, beliefs, and 
end of life care options in order to facilitate best interest decision-making.  In the second 
meeting, family carers had the opportunity to review a draft advance care plan 
developed by the facilitator based on their previous discussion, to address any 
outstanding issues, and sign the standardized advance care plan document, retaining a 
personal copy. As a follow-up to the family meetings, the advance care plan was placed 
in the resident’s medical records following orientation on the contents with the nurse-
in-charge, and a copy was sent to the resident’s GP.   
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Outcome measures 
The primary outcome was family carer uncertainty in decision-making about the care of 
the resident. This was measured using the 16-item Decisional Conflict Scale (DCS) in 
which items were scored, averaged and transformed to provide an overall score 30 The 
instrument also provides five subscales:  1) ‘Informed’, which measures awareness of 
options, benefits, and risks; 2) ‘Values Clarity’, which measures feelings of support, 
advice, and pressure from others; 3) ‘Support’, which measures the perceived level of 
support in decision making; 4) ‘Uncertainty’, which measures the respondent’s degree 
of confidence about the decision; and, 5) ‘Effective Decision’ measures the likelihood of 
adhering to the decision and satisfaction with the decision.  
 
Secondary outcomes included family carer satisfaction with nursing home care, 
measured by the Family Perceptions of Care Scale (FPCS).31  This 25-item scale was 
designed to assess family carer perceptions of the care given to a family member in the 
last four weeks of life.  On the basis of pilot testing, the tense was adjusted to recognise 
that the resident was not deceased.  The FPCS provides an overall score as well as  four 
subscales scores: 1) ‘Resident Care’, which measures family members opinions of care 
provided to the resident; 2) ‘Family Support’, reports on perceptions of nursing home 
care directed towards family members to assist family members to assist them with 
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decision-making; 3) ‘Communication’, concerning the timeliness, comprehensiveness, 
and clarity of the communication between staff and the family member; and 4) 
‘Rooming’ assessing perception of appropriate placement of the resident in the facility. 
Additionally, family carer psychological distress was measured using the General Health 
Questionnaire (GHQ).32 The GHQ is a 12-item self-report instrument which measures 
psychological morbidity.  If a resident died during the data collection period family carers 
received the Quality of Dying in Long-Term Care instrument (QOD-LTC)33 four weeks 
after the death. Staff involved in the care of the resident received the QOD-LTC one 
week after the death. The 11-item instrument assessed the quality of dying experience.  
 
Nursing home administrative records of residents whose family member participated in 
the study were reviewed for six months after the completion of the follow-up 
questionnaire. The review examined hospitalisation rates; completion rates for Do Not 
Resuscitate (DNR) orders; and, place of death. 
 
Analysis 
Frequencies were determined for categorical variables and summary statistics (using 
mean and standard deviation for approximately symmetrical variables) were calculated 
for quantitative variables.  The primary analysis for the continuous outcomes was 
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conducted using a two-stage method, using meta-analysis models, recommended for 
the analysis of paired cluster randomized trials.34  First, for each outcome, analysis of 
covariance was used to calculate the difference in mean (and accompanying standard 
error) between the intervention and control group adjusting for baseline35 within the 11 
pairs of homes.  This difference in mean (and standard error) was then pooled using a 
random effects meta-analysis model to calculate the pooled difference in mean and 95% 
CI.34  Chi-squared tests were conducted and I2 statistics (measuring the proportion of 
the variation in the treatment estimate due to heterogeneity) were calculated to 
determine the consistency of the treatment effect across the paired clusters.36  
Secondary outcomes based upon proportions which had small cell counts (e.g. 
hospitalisations, DNRs and place of death) were analysed by calculating the proportion 
at the home level and then using a Wilcoxon-signed rank test to compared these 
proportions between the intervention and control groups.37  A separate sensitivity 
analysis, recommended for missing outcome data when a baseline is available38, was 
conducted for the primary outcome.  Specifically, within the pairs of homes a covariate 
adjusted complete-case analysis was conducted with variables included in the model 
(specifically age, gender and FAST score) which could be associated with outcome or 
probability of missingness and the random effects meta-analysis model was used to pool 
15 
 
these estimates as previously (not shown as estimates were similar to the main analysis).  
All analyses were conducted in STATA 14.39   
 
Results 
Subsequent to pilot testing, 24 homes were randomized before baseline data collection. 
One nursing home in the usual care group withdrew from the study prior to family carers 
being contacted because of competing workload priorities and the inability to 
accommodate the project. Participants were recruited from January 2015 until 
September 2015.   
 
Insert Figure 1 about here 
 
Figure 1 reveals that 695 family carers were eligible to participate in the trial: 38 were 
removed from the study as their mailing address was incorrect or their family member 
had either recently died or were discharged prior to the mailing of baseline 
questionnaires. This resulted in an adjusted sample of 657 family carers who were 
mailed the baseline questionnaire.  The overall response rate in the initial baseline mail-
out was 197 (30%), 36% response rate in the usual care group and 24% for the 
intervention group.  
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In the intervention group 67 (84%) of the 80 individuals who completed the baseline 
questionnaire also completed the intervention with 61 family carers completing the 
follow-up questionnaire (Figure 1).  In the usual care group 117 family carers completed 
the baseline questionnaire and 98 (84%) family carers completing the follow-up 
questionnaire.  
 
Table 1 shows characteristics for family carers and their relative residing in the nursing 
home.  Most family carers were identified as daughters of the resident and most 
residents were identified as having moderately severe to, severe dementia.   
 
Insert Table 1 around here 
 
ACP family meetings were delivered to 67 out of 80 participants who completed the 
baseline questionnaire in the intervention group (Figure 1).  On average the meetings 
lasted 60 minutes. Most family carers attended the family meetings on their own 69% 
(n= 46) but typically reported that they consulted with family members between the 
meetings.  ACP facilitator time for each family encounter was on average 130 minutes, 
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including administration, conducting the meetings, drafting an ACP and liaising with 
nursing home staff.   
 
Family carers identified preferences for future care that typically included their relative 
be pain free and in comfort; non-essential medication to be discontinued; their relative 
to be able to die in the nursing home; availability of religious support; nursing home staff 
to provide the resident emotional support in the family’s absence, and to notify the 
family when the resident’s condition deteriorated. Family carers specified that they 
wanted to be consulted on decisions concerning transfer to a hospital to avoid 
unnecessary hospitalizations; to avoid life prolonging measures if there was little or no 
significant hope of improving quality of life; and for those family residents with a DNR in 
place that resuscitation was avoided.   
 
Insert Table 2 around here 
 
An examination of the total mean score and sub-scores of the DCS at baseline (T1) and 
follow-up (T2) in the intervention and control groups suggests evidence of effectiveness 
(Table 2).  There was evidence of a difference between the intervention and usual care 
group on the total DCS score at 7 weeks after adjusting for baseline (-10.5, 95% 
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confidence interval (CI) -16.4 to -4.7; p < 0.001).  There was marked heterogeneity in the 
association across the 11 pairs of homes (I2=58%, heterogeneity p = 0.01).  On closer 
inspection (see Figure 2), this was largely due to a larger effect in Pair 2. After omitting 
Pair 2 from the overall analysis, the effect remained (-8.4, 95% CI -13.1 to -3.7; p = 0.001) 
and the heterogeneity was reduced (I2=32%, heterogeneity p = 0.15).  Evidence of 
differences between the intervention and usual care group on all subscales of the DCS 
(Table 2) were also revealed.  
 
Insert Figure 2 about here 
Insert Table 3 around here 
 
Table 3 reports the findings for the secondary outcomes GHQ and the FPCS at T1 and 
T2.  There was little evidence of a difference between the intervention and usual care 
group on the total GHQ score at 7 weeks after adjusting for baseline. This result was 
fairly consistent across pairs (I2=26%, heterogeneity p= 0.19).  There was evidence of a 
difference in the total FPCS total score between the intervention and usual care group 
after adjusting for baseline (8.6, 95% CI 2.3 to 14.8; p = 0.01), which was also fairly 
consistent across pairs (I2=14%, heterogeneity p= 0.31).  This difference was driven by 
the two subscales; ‘Family Support’ and ‘Communication’.   Six residents died during the 
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data collection period.  A low response rate did not allow for analysis of the QOD-LTC 
between the two groups.  
 
Insert Table 4 around here 
 
Table 4 shows the increase in DNRs, and reductions in hospital admissions and deaths in 
the intervention group compared with the usual care group but none of these 
differences were statistically significant. While there was a reduction in admissions in 
the ACP group of around 11% (7% versus 18%) we cannot rule out the possibility of a 
type 2 error i.e. that there are reductions in hospital admissions but we did not detect 
them as statistical significant.  
 
Discussion 
In this paired cluster randomized trial, the ACP intervention significantly reduced family 
carer uncertainty in decision-making concerning the care of the family member; and, 
improved family carer satisfaction in nursing home care. However the intervention did 
not have a detectable impact on family carer psychological distress; the number of 
completed DNRs; reduced hospitalisations; or, number of deaths in a hospital.  
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Flo et al17 conducted a review of ACP in nursing homes and reported that most studies 
had tested different interventions, with staff education being the most common 
(learning courses and practical training). While most studies targeted nursing home staff 
for education, some interventions similar to ours, focused on providing information and 
education to family carers regarding the terminal nature of dementia.  As was the case 
in our study, most previous studies did not use nursing home residents as study 
informants. Those studies that did include residents excluded those with advanced 
dementia.    
 
The challenge of recruiting family carers in this type of research is noteworthy. In our 
case, the cross-sectional approach to recruitment generated low initial response from 
family carers.  This observation highlights what is recognized in the literature, that 
successful ACP engagement, is predicated on the initiation of a health care provider who 
is engaged in a trusting relationship and who recognizes the importance of timing when 
to initiate ACP discussions.40  
 
The booklet that we used for family carer education ‘Comfort care at the end of life for 
persons with Alzheimer’s Disease or other Degenerative Diseases of the Brain’ has been 
shown through multi-country studies to have high levels of acceptability among family 
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carers, nurses and physicians18, 26-27 and the WHO has identified the booklet as a best 
practice instrument28.  The tools used in previous ACP intervention studies have been 
diverse. However, it was commonly viewed across studies, as in our work, that ACP is a 
decision-making process. Flo et al17 further noted variation across studies on the level 
of formalization of the ACP conversation and its documentation. In our study family 
meetings were implemented using a standardized approach based on clinical practice 
guidelines 29.  Furthermore, advance care plan documentation was also standardized.  
 
Despite the widespread acceptance of relying on family carers  in best interest decision 
making, the presence of family carer stress and conflict around the ‘right’ decision 
makes the decision-making process challenging. The concern for a ‘right decision’ shifts 
the importance of ACP as a means to support best-interest decision-making, where 
consideration is whether a decision is the least restrictive of a person’s right or 
freedom.41   
 
Our study has both strength and limitations. We showed that the intervention was 
successful for the target population. An important feature of our study was that 
participants were offered a standardized ACP approach allowing for generation of a 
detailed description of the intervention and its implementation.  Explicit details on the 
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model and its operation facilitates the opportunity to disseminate the model to other 
nursing home settings.  Another important strength of our study is the use of cluster 
randomization of nursing homes to avoid contamination between participants in the 
intervention and control groups. The paired nature of our design also allowed the 
balancing of potential confounding variables to ensure similarity between groups. We 
also utilised internationally recognized and widely used outcome instruments.   
 
Our study has some limitations. One limitation was the inability to blind the allocation 
between randomization and data collection. Nursing homes had to be randomized 
before we collected baseline data, which reduced the internal validity of the study, as 
did the lack of blinding for follow-up data. The accuracy of nursing home reports of DNR, 
hospitalisations and location of death was dependent on nursing home manager access 
to records and also record keeping. While the study did not include an economic analysis 
it did record time spent by the ACP facilitator on a family case basis. This information 
can be used to estimate manpower costs and inform commissioning business cases. 
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Implications for Practice and Policy  
This paired cluster randomized trial indicates that it is feasible to implement an ACP 
intervention in dementia care nursing homes with effective outcomes.  Implications for 
clinicians and policy makers include recognizing the importance of improving 
communication between family carers and formal care providers who are involved in 
24 
 
resident nursing home care.  Secondly, family carer education is essential to enable 
family carers to weigh the burden or benefit of treatment options when the family 
member enters the late stages of dementia.  Furthermore, ACP needs to become part 
of the usual nursing home care involving various formal care providers such as the 
resident’s GP and nursing home staff.  In conclusion, it should be recognized that the 
approach pursued in cultivating and supporting sustainable ACP expertise will be shaped 
by broader nursing home conditions and should be accounted for in practice and policy 
deliberations.  
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Table 1. Respondents’ characteristics at baseline. Values are numbers (percentages). 
  As randomised Included in main analysis 
Characteristics 
Intervention 
(n = 79) 
Usual Care 
(n = 117) 
Intervention 
(n = 51) 
Usual Care 
(n = 91) 
Gender     
Male 15 (19.0) 45 (38.5) 8(15.7) 34(37.4) 
Female  64 (81.0) 72 (61.5) 43(84.3) 57(62.6) 
Age     
Mean (SD) 61.6 (11.8) 59.9 (10.6) 61.6(11.6) 60.3(11.0) 
Range n(%)     
18-30  1 (1.3) 0 (0.0) 1(2.0) 0(0.0) 
31-40  2 (2.5) 3 (2.6) 1(2.0) 3(3.3) 
41-50  9 (11.4) 17(14.5) 5(9.8) 12(13.2) 
51-60  21 (26.6) 39 (33.3) 15(29.4) 33(36.3) 
61-70  26 (32.9) 24 (20.5) 17(33.3) 17(18.7) 
71-80  8 (10.1) 18 (15.4) 3(5.9) 17(18.7) 
81-90  5 (6.3) 2 (1.7) 4(7.8) 2(2.2) 
Relationship of care home 
resident 
    
Parent 44 (55.7) 70 (59.8) 28(54.9) 53(58.2) 
Spouse 12 (15.2) 20 (17.1) 7(13.7) 16(17.6) 
Sibling 5 (6.3) 6 (5.1) 4(7.8) 6(6.6) 
Extended family 18 (22.8) 20 (17.1) 12(23.5) 15(16.5) 
FAST Score     
Mild dementia 2(2.5) 2(1.7) 1(2.0) 2(2.2) 
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Moderate dementia 2(2.5) 4(3.4) 1(2.0) 3(3.3) 
Moderately severe dementia 49 (62.0) 54 (46.2) 34(66.7) 45(49.5) 
Severe dementia 26 (32.9) 57 (48.7) 15(28.4) 41(45.1) 
FAST: Functional Assessment Staging Tool.  
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Table 2. Comparison of primary outcome decisional conflict scale (DCS) between the control 
and intervention group. 
Primary 
Outcomes 
Time 
Control Intervention Difference in 
meanb 
 (95% CI) 
P 
I2 
(hetero P) na mean (SD) na mean (SD) 
Total DCS Score 
T1c 91 34.7(21.0) 51 28.3(22.3)    
T2d 91 30.7(20.5) 51 18.3(19.7) -10.5(-16.4, -4.7) <0.001 58% (0.01) 
DCS Subscore: 
Informed 
T1 94 39.5(26.2) 56 33.8(26.0)    
T2 94 37.4(25.7) 56 20.2(22.7) -15.0(-22.0, -8.0) <0.001 58% (0.01) 
DCS Subscore: 
Values clarity 
T1 94 36.2(24.8) 55 33.2(28.3)    
T2 94 32.5(24.0) 55 21.2(25.2) -12.8(-24.1, -1.6) 0.03 75% (<0.01) 
DCS Subscore: 
Support 
T1 95 31.6(21.5) 55 26.8(24.2)    
T2 95 27.4(20.9) 55 17.1(19.5) -7.7(-12.9, -2.5) <0.001 16% (0.29) 
DCS Subscore: 
Uncertainty 
T1 94 38.2(22.2) 54 34.4(27.5)    
T2 94 31.8(21.2) 54 21.6(21.6) -8.3(-14.5, -2.2) 0.01 34% (0.13) 
DCS Subscore: 
Effective decision 
T1 94 29.6(21.7) 54 24.4(22.1)    
T2 94 25.8(19.7) 54 16.8(21.0) -7.3(-11.5, -3.0) <0.001 1% (0.44) 
aNumbers only include those who contribute at both time points. 
bPooled difference in mean adjusting for baseline, summarized at pair home level and pooled 
across homes using meta-analysis. 
cTime 1 baseline. 
dTime 2 follow-up. 
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Table 3. Comparison of secondary outcomes General Health Questionnaire (GHQ) and Family 
Perception of Care Scale (FPCS) between intervention and control group. 
 
Secondary 
outcomes 
Time 
Control Intervention  Difference in 
meanb 
(95% CI) 
P 
I2 
(hetero P) na mean (SD) na mean (SD) 
Total GHQ Score 
T1c 88 12.6(6.1) 55 11.4(5.3)    
T2d 88 11.6(5.4) 55 9.9(6.1) -0.5(-1.9, 0.8) 0.44 
26% 
(0.19) 
Total FPCS Score 
T1 88 131.0(22.9) 42 138.0(21.4)    
T2 88 133.6(23.8) 42 144.6(25.6) 8.6(2.3, 14.8) 0.01 
14% 
(0.31) 
FPCS Subscale: 
Resident Care 
T1 91 59.1(11.3) 46 61.6(10.6)    
T2 91 60.1(11.4) 46 63.6(12.3) 2.1(-0.5, 4.7) 0.11 
9%   
(0.36) 
FPCS Subscale: 
Family Support 
T1 91 26.8(7.1) 45 28.7(7.1)    
T2 91 28.2(7.3) 45 32.7(7.2) 3.9(1.7, 6.1) <0.001 
16% 
(0.29) 
FPCS Subscale: 
Communication 
T1 96 33.1(5.2) 52 34.3(6.9)    
T2 96 33.2(5.4) 52 35.6(6.9) 2.2(0.8, 3.6) <0.001 
27% 
(0.19) 
FPCS Subscale: 
Rooming 
T1 95 12.2(1.8) 56 12.9(1.2)    
T2 95 12.2(1.9) 56 12.7(1.9) 0.3(-0.2, 0.9) 0.21 
31% 
(0.15) 
a Numbers only include those who contribute at both time points. 
bPooled difference in mean adjusting for baseline, summarized at pair home level and pooled 
across homes using meta-analysis. 
c Time 1 baseline. 
d Time 2 follow-up. 
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Table 4. Do Not Resuscitate orders (DNRs), hospitalizations and location of death. 
 
 Usual Care Intervention Pa 
No. of completed 
DNRsb 
23 (42%)c 21 (51%) 0.18  
Hospital admissionsb 17 (18%)  5 (7%) 0.12  
Location of deathb:    
Nursing home 24 (80%) 12 (86%)  
Hospital 6 (20%) 2 (14%) 0.94  
DNR: Do Not Resuscitate.  
aP-value based upon a Wilcoxon sign rank comparison of paired home proportions. 
bDuring 6 months after last point of contact with study. 
cOut of people on whom DNR information was available and were know not to have a DNR at 
the start of the study. 
 
